Clinical Trial Update: CBD for Knee Osteoarthritis [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial is evaluating cannabidiol (CBD) for knee osteoarthritis in Phase 1/2. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis of the Knee

Drugs mentioned

• Cannabidiol (CBD) (cannabidiol)

Snippet

Sponsor: University of Florida | Conditions: Osteoarthritis, Knee | Phase 1, Phase 2 | Status: RECRUITING